News

Three doses of COVID-19 mRNA vaccination induce long-lasting antibody and memory B-cell responses, according to a study of ...
Very few humans have gone up against bird flu. But we've all dealt with seasonal flu for years. Some of our immune systems might be primed to fend off a worse case, research finds.
Exposure to neonatal antibiotics reduces antibody production against such polysaccharides, weakening the immune response. Experiments on germ-free mice revealed that the lower immune response was ...
Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.
At the recent European Society of Clinical Microbiology and Infectious Diseases (ESCMID) meeting in Vienna, Longhorn Vaccines & Diagnostics LLC presented data on the neutralizing antibody responses of ...
This work is published in Nature Medicine in the paper, “Immune history shapes human antibody responses to H5N1 influenza viruses.” “We know that early childhood influenza exposures can ...
A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates ...
“These monoclonal antibodies also tell us about the diversity of immune response mounted by different individuals, and even the diversity of the immune response within a single person,” she adde ...
Three doses of COVID-19 mRNA vaccination induce long-lasting antibody and memory B-cell responses, according to a study of 113 healthcare workers in Catalonia who were followed during three years. The ...